Marshall Wace North America L.P. - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$79,000
-39.7%
16,888
-9.4%
0.00%
-100.0%
Q2 2021$131,000
-73.9%
18,642
-44.2%
0.00%
-66.7%
Q3 2019$501,00033,3800.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 4,681,858$21,583,0000.30%
Ghost Tree Capital, LLC 200,000$922,0000.20%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$8,694,0000.10%
PDT Partners, LLC 67,100$309,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 13,908$64,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 195,651$902,0000.01%
WEXFORD CAPITAL LP 8,365$39,0000.01%
Virtu Financial LLC 10,133$47,0000.01%
WINTON GROUP Ltd 11,911$55,0000.00%
Engineers Gate Manager LP 13,678$63,0000.00%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders